| (210) | Number of the EPO application | 19832954 |
| (220) | Filing date of the EPO application | 2019.12.20 |
| (80) | EPO patent specification publication (B) | EPB nr. 21/2024, 2024.05.22 |
| (110) | EPO patent number | 3897646 |
| (21) | Number of the application | e 2021 1045 |
| (71) | Name(s) of applicant(s), code of the country | Actelion Pharmaceuticals Ltd, CH; |
| (72) | Name(s) of inventor(s), code of the country | CSONKA Dénes, CH;
FARES Wassim, US;
HOOGKAMER Hans, CH;
TORFS Koen, BE; |
| (73) | Name(s) of owner(s), code of the country | Actelion Pharmaceuticals Ltd, CH; |
| (54) | Title of the invention | MACITENTAN FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 31/506 (2006.01.01); A61P 9/12 (2006.01.01); A61P 11/00 (2006.01.01) |
| (19) | Country | CH |
| (41) | Date of publication of the application | 2021.11.30 |
| (30) | Priority | PCT/EP2018/0867, 2018.12.21, WO; PCT/EP2019/0518, 2019.01.25, WO; PCT/EP2019/0601, 2019.04.18, WO; PCT/EP2019/0664, 2019.06.21, WO; PCT/EP2019/0671, 2019.06.27, WO |
| (86) | International application | PCT/EP2019/086754, 2019.12.20 |
| (87) | International publication | WO 2020/128017, 2020.06.25 |